Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Allocation / Balanced · MFS

NYLI Income Builder Fund Class C (MCTRX)

Ticker MCTRX · Since 1998-09-01 · · Holdings as of Jul 31, 2026

Expense ratio
2.03%$203/yr per $10k
5-yr return
+5.2%annualized
1-yr return
+14.5%as of Dec 2025
Net assets
$1.2Ball share classes
Holdings
644

Bottom line

Is MCTRX a good fund? The bottom line

MCTRX is the Class C share class of NYLI Income Builder Fund, a managed allocation / balanced mutual fund from MFS.

It charges 2.03% — about $203 a year on every $10,000 invested, more expensive than 96% of allocation / balanced funds we track.

It returned +14.5% over one year, +5.2% a year over five years, +6.0% a year over ten (as of Dec 31, 2025, per its prospectus).

With $1.2 billion in net assets and 644 holdings, its largest position is United States of America (2.6%) and the top 10 make up 14.7% of the portfolio.

What stands out

  • Broadly diversified (644 holdings)
  • No front-end sales load

What to watch

  • Expensive for its category (2.03%)
  • 12b-1 marketing fee of 1% a year

Updated Nov 19, 2026

What MCTRX invests in

The Fund seeks current income consistent with reasonable opportunity for future growth of capital and income.

"The Fund normally invests a minimum of 30% of its net assets in equity securities and a minimum of 30% of its net assets in debt securities. From time to time, the Fund may temporarily invest less than 30% of its net assets in equity or debt securities as a result of market conditions, individual securities transactions or cash flow considerations. Asset Allocation Investment Process : Asset allocation decisions are made by a Committee chaired by New York Life Investment Management, the Funds Manager, in collaboration with MacKay Shields LLC (MacKay Shields), the subadvisor for the fixed-income portion of the Fund. Asset allocation decisions are determined based on the relative values of each asset class, inclusive of the ability of each asset class to generate income. The Fund may use equity index and fixed-income futures to manage effective exposure, for example, by adding exposure…

From the fund's prospectus (filed Feb 26, 2026).

MCTRX performance

Average annual total returns
1 yr5 yr10 yr
MCTRX+14.5%+5.2%+6.0%
Allocation / Balanced median+11.0%+5.7%+6.7%

Source: Fund prospectus, as of Dec 31, 2025

Full MCTRX performance history →

What MCTRX costs

On a $10,000 investment, MCTRX's 2.03% expense ratio costs about $203 a year. The prospectus estimates $2,205 in total costs over 10 years (assuming 5% annual returns). The median allocation / balanced fund charges 0.91%.

See the full MCTRX fee table →

MCTRX top 10 holdings

#Holding% of fund
1United States of America2.62%
2United States of America1.60%
3Hewlett Packard Enterprise Co.1.44%
4Microsoft Corp.1.41%
5Cisco Systems, Inc.1.37%
6Dell Technologies, Inc.1.32%
7CVS Health Corp.1.29%
8Taiwan Semiconductor Manufacturing Co. Ltd.1.29%
9Broadcom, Inc.1.27%
10Texas Instruments, Inc.1.14%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 14.7% of the fund. See all top 25 holdings and asset mix →

Alternatives to MCTRX

More funds like MCTRX →

MCTRX FAQ

What is the expense ratio of MCTRX?
MCTRX's expense ratio is 2.03%, which works out to about $203 a year for every $10,000 invested. The prospectus estimates total costs of $2,205 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is MCTRX a good investment?
It depends on your goals, but the data points to: broadly diversified (644 holdings); no front-end sales load; expensive for its category (2.03%); 12b-1 marketing fee of 1% a year. This is general information, not personalized advice.
What does MCTRX hold?
MCTRX's largest holdings are United States of America (2.6%), United States of America (1.6%), Hewlett Packard Enterprise Co. (1.4%), Microsoft Corp. (1.4%), Cisco Systems, Inc. (1.4%). It holds 644 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
What is MCTRX's 5-year return?
MCTRX returned +5.2% a year over the five years ending Dec 31, 2025, and +6.0% a year over ten years. Past performance does not guarantee future results.
Does MCTRX have a sales load?
No. MCTRX has no front-end sales charge. It may charge a deferred sales charge of up to 1% if sold early.
Who manages MCTRX?
MCTRX is offered by MFS through New York Life Investments Funds.